TONIX Pharmaceuticals Presents Findings on the Effects of Bedtime Very Low Dose (VLD) Cyclobenzaprine (CBP) on Symptoms and Sleep Physiology in Patients with Fibromyalgia Syndrome - Drugs.com MedNews
Links shared publicly online about this topic.
- 214total visits
TONIX Pharmaceuticals Presents Findings on the Effects of Bedtime Very Low Dose (VLD) Cyclobenzaprine (CBP) on Symptoms and Sleep Physiology in Patients with Fibromyalgia Syndrome - Drugs.com MedNews
Presented at the Associated Professional Sleep Societies, June 2011 25th Anniversary Meeting in Minneapolis, MN Jun 16, 2011 - TONIX Pharmaceuticals, a specialt
View full resource at drugs.com
Tags: Sleep, Fibromyalgia, Drug, Pharma, Muscle Relaxer, Flexeril
Most Recently Shared on June 16, 2011 at 5:13 pm By:
TONIX Pharmaceuticals Presents Findings on the Effects of Bedtime Very Low Dose (VLD) Cyclobenzaprine (CBP... http://bit.ly/iMR6o1 #drug
TONIX Pharmaceuticals Presents Findings on the Effects of Bedtime Very Low Dose (VLD) Cyclobenzaprine (CBP) on Symptoms and Sleep Physiology in Patients with Fibromyalgia Syndrome - News Press Release | PharmiWeb.com
pharmiweb.com — “TONIX Pharmaceuticals Presents Findings on the Effects of Bedtime Very Low Dose (VLD) Cyclobenzaprine (CBP) on Symptoms and Sleep Physiology in Patients with Fibromyalgia Syndrome - News Press Release | PharmiWeb.com” View full resource at pharmiweb.com
Most Recently Shared on June 16, 2011 at 7:12 pm By:
Press Release: TONIX Pharmaceuticals, a specialty pharmaceutical company developing therapies for challenging di... http://bit.ly/kiSUsq
Advertisement
